• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Natural Killer/T-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.

作者信息

Motabi Ibraheem, Alzahrani Musa, Dada Reyad, Al-Mansour Mubarak, Alhashmi Hani, Kandil Magdy, Sagheir Ahmed, Alhejazi Ayman

机构信息

Department of Adult Hematology and BMT, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Saudi J Med Med Sci. 2019 Sep-Dec;7(3):222-225. doi: 10.4103/sjmms.sjmms_104_19. Epub 2019 Aug 28.

DOI:10.4103/sjmms.sjmms_104_19
PMID:31543749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6734723/
Abstract
摘要

相似文献

1
Natural Killer/T-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.自然杀伤细胞/ T细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理和随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):222-225. doi: 10.4103/sjmms.sjmms_104_19. Epub 2019 Aug 28.
2
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.
3
Mantle Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.套细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):226-230. doi: 10.4103/sjmms.sjmms_105_19. Epub 2019 Aug 28.
4
Diffuse Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.弥漫性大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):209-213. doi: 10.4103/sjmms.sjmms_98_19. Epub 2019 Aug 28.
5
Primary Mediastinal Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性纵隔大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):231-233. doi: 10.4103/sjmms.sjmms_106_19. Epub 2019 Aug 28.
6
Follicular Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.滤泡性淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):214-218. doi: 10.4103/sjmms.sjmms_101_19. Epub 2019 Aug 28.
7
Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.霍奇金淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):195-201. doi: 10.4103/sjmms.sjmms_96_19. Epub 2019 Aug 28.
8
Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.边缘区淋巴瘤：沙特淋巴瘤组诊断、管理及随访临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):202-208. doi: 10.4103/sjmms.sjmms_97_19. Epub 2019 Aug 28.
9
Primary Central Nervous System Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性中枢神经系统淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):219-221. doi: 10.4103/sjmms.sjmms_103_19. Epub 2019 Aug 28.
10
Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.绝对淋巴细胞计数/绝对单核细胞计数比值及预后评分对鼻型结外自然杀伤/T细胞淋巴瘤患者的预后影响
Tumour Biol. 2017 May;39(5):1010428317705503. doi: 10.1177/1010428317705503.

引用本文的文献

1
Perspectives on the Mature T-Cell Lymphomas in the Middle East: A Comprehensive Review of the Present Status.中东地区成熟T细胞淋巴瘤的研究现状：综合综述
Cancers (Basel). 2024 Dec 11;16(24):4131. doi: 10.3390/cancers16244131.
2
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.

本文引用的文献

1
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.帕博利珠单抗的 PD1 阻断在 l-天冬酰胺酶治疗失败的复发或难治性 NK/T 细胞淋巴瘤中具有高度疗效。
Blood. 2017 Apr 27;129(17):2437-2442. doi: 10.1182/blood-2016-12-756841. Epub 2017 Feb 10.
2
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.2000 年至 2013 年间诊断的结外自然杀伤/T 细胞淋巴瘤患者的治疗和结局：日本的一项合作研究。
J Clin Oncol. 2017 Jan;35(1):32-39. doi: 10.1200/JCO.2016.68.1619. Epub 2016 Oct 31.
3
2016 US lymphoid malignancy statistics by World Health Organization subtypes.2016年按世界卫生组织亚型分类的美国淋巴系统恶性肿瘤统计数据。
CA Cancer J Clin. 2016 Nov 12;66(6):443-459. doi: 10.3322/caac.21357. Epub 2016 Sep 12.
4
Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma.培门冬酶、吉西他滨和奥沙利铂联合夹心放疗治疗初治结外自然杀伤（NK）/T细胞淋巴瘤的疗效与耐受性
Leuk Res. 2016 Aug;47:26-31. doi: 10.1016/j.leukres.2016.05.004. Epub 2016 May 12.
5
Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population.非亚洲人群中鼻型结外NK/T细胞淋巴瘤治疗的鼓舞人心的经验。
Leuk Lymphoma. 2016 Nov;57(11):2575-83. doi: 10.1080/10428194.2016.1180689. Epub 2016 May 17.
6
Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma.吉西他滨、奥沙利铂和聚乙二醇天冬酰胺酶联合方案治疗NK/T细胞淋巴瘤的疗效及安全性分析
Oncotarget. 2016 Jun 7;7(23):35412-22. doi: 10.18632/oncotarget.8643.
7
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.DDGP 方案与 SMILE 方案治疗初治中高危 NK/T 细胞淋巴瘤的随机对照、多中心、开放标签研究 **解析**：原文是一篇医学研究论文的标题，包含了医学专业术语“Natural Killer/T-Cell Lymphoma”，意思是“自然杀伤/T 细胞淋巴瘤”。译文忠实反映了原文的内容，准确传达了其含义。
Clin Cancer Res. 2016 Nov 1;22(21):5223-5228. doi: 10.1158/1078-0432.CCR-16-0153. Epub 2016 Apr 8.
8
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.非蒽环类药物治疗后自然杀伤细胞淋巴瘤的预后指数：一项多中心回顾性分析。
Lancet Oncol. 2016 Mar;17(3):389-400. doi: 10.1016/S1470-2045(15)00533-1. Epub 2016 Feb 10.
9
Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.新诊断的IE期至IIE期鼻型结外自然杀伤/T细胞淋巴瘤“三明治”放化疗2期试验的五年分析
Cancer Med. 2016 Jan;5(1):33-40. doi: 10.1002/cam4.569. Epub 2015 Dec 2.
10
First-line combination of GELOX followed by radiation therapy for patients with stage IE/IIE ENKTL: An updated analysis with long-term follow-up.对于IE/IIE期鼻型结外NK/T细胞淋巴瘤患者，一线采用GELOX方案联合后续放疗：长期随访的最新分析
Oncol Lett. 2015 Aug;10(2):1036-1040. doi: 10.3892/ol.2015.3327. Epub 2015 Jun 5.